Literature DB >> 20385435

Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003.

Virginia Wang1, Shoou-Yih D Lee, Uptal D Patel, Bryan J Weiner, Thomas C Ricketts, Morris Weinberger.   

Abstract

BACKGROUND: Peritoneal dialysis (PD) is the preferred dialysis modality for many patients with end-stage renal disease (ESRD) in the United States. However, in sharp contrast to the high rates of PD use in other industrialized countries, PD use in the United States is low and decreasing. PD availability is a necessary condition for PD use; however, little is known about the availability and geographic distribution of PD services. This study describes trends in the regional supply of PD services in dialysis facilities between 1995 and 2003. STUDY
DESIGN: Longitudinal cohort study. SETTING & PARTICIPANTS: Nonfederal outpatient dialysis facilities treating patients with ESRD in the United States using data from the US Renal Data System. PREDICTORS: Annual ESRD patient and dialysis facility composition in hospital referral regions. OUTCOME: Annual proportion of dialysis facilities offering PD treatment services in hospital referral regions.
RESULTS: The average proportion of facilities offering PD services in hospital referral regions was 56% in 1996, which decreased to 47% in 2003. There was geographic variation in PD services, with greater PD availability in metropolitan cities (compared with rural regions) and the Northeast (relative to the South and Midwest). Variation in PD availability was not explained by disease trends or patient characteristics believed to be important for PD use. An increasing regional presence of chain-affiliated facilities was associated with less PD supply. LIMITATIONS: Accuracy of patient registry data, inability to account for consolidation of PD services among chain providers, sensitivity of results to definition of regional markets.
CONCLUSIONS: The small and decreasing availability of PD therapy seems counterintuitive given its demonstrated appeal to patients and payers. Further research is needed to investigate dialysis facilities' role in the underuse of a potentially useful therapy. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20385435      PMCID: PMC3664519          DOI: 10.1053/j.ajkd.2010.01.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  40 in total

1.  Preliminary findings from the National Pre-ESRD Education Initiative.

Authors:  M Schreiber; E Ilamathi; M Wolfson; D Fender; S Mueller; M Baudoin
Journal:  Nephrol News Issues       Date:  2000-11

2.  Why is the proportion of patients doing peritoneal dialysis declining in North America?

Authors:  P G Blake; F O Finkelstein
Journal:  Perit Dial Int       Date:  2001 Mar-Apr       Impact factor: 1.756

3.  A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs.

Authors:  Hacer Ozgen; Yasar A Ozcan
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

4.  Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease.

Authors:  Dana C Miskulin; Klemens B Meyer; Nicolaos V Athienites; Alice A Martin; Norma Terrin; Jane V Marsh; Nancy E Fink; Josef Coresh; Neil R Powe; Mike J Klag; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

5.  The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis.

Authors:  George C Kim; Edward F Vonesh; Stephen M Korbet
Journal:  Perit Dial Int       Date:  2002 Jan-Feb       Impact factor: 1.756

6.  Are North American nephrologists biased against peritoneal dialysis?

Authors:  A F Charest; D C Mendelssohn
Journal:  Perit Dial Int       Date:  2001 Jul-Aug       Impact factor: 1.756

7.  Determinants of modality selection among incident US dialysis patients: results from a national study.

Authors:  Austin G Stack
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

8.  Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.

Authors:  Helen Lee; Braden Manns; Ken Taub; William A Ghali; Stafford Dean; David Johnson; Cam Donaldson
Journal:  Am J Kidney Dis       Date:  2002-09       Impact factor: 8.860

9.  Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes.

Authors:  Rajnish Mehrotra; Osman Khawar; Uyen Duong; Linda Fried; Keith Norris; Allen Nissenson; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2009-04-08       Impact factor: 8.860

10.  An analysis of dialysis training in the United States and Canada.

Authors:  Rajnish Mehrotra; Peter Blake; Nancy Berman; Karl D Nolph
Journal:  Am J Kidney Dis       Date:  2002-07       Impact factor: 8.860

View more
  15 in total

1.  Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States.

Authors:  Rajnish Mehrotra; Melissa Soohoo; Matthew B Rivara; Jonathan Himmelfarb; Alfred K Cheung; Onyebuchi A Arah; Allen R Nissenson; Vanessa Ravel; Elani Streja; Sooraj Kuttykrishnan; Ronit Katz; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2015-12-10       Impact factor: 10.121

2.  Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

Authors:  Karen H Costenbader; Amrita Desai; Graciela S Alarcón; Linda T Hiraki; Tamara Shaykevich; M Alan Brookhart; Elena Massarotti; Bing Lu; Daniel H Solomon; Wolfgang C Winkelmayer
Journal:  Arthritis Rheum       Date:  2011-06

3.  Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.

Authors:  Amy Devlin; Sushrut S Waikar; Daniel H Solomon; Bing Lu; Tamara Shaykevich; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-12       Impact factor: 4.794

4.  Comparison of mortality of ESRD patients with lupus by initial dialysis modality.

Authors:  Gabriel Contreras; Javier Pagan; Ruchir Chokshi; Sharad Virmani; Jorge M Diego; Patricia Byers; Tamara Isakova; Jair Munoz Mendoza; Ali Nayer; Jose Roberto Contreras; Gabriel Panama; Oliver Lenz; Maria Carpintero; Timothy Muchayi; David Roth
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 8.237

5.  Geographical Variation in Peritoneal Dialysis Catheter Insertion and Initiation within the United States.

Authors:  Achint Patel; Harshil Shah; Shanti Patel; Girish N Nadkarni; Jaime Uribarri
Journal:  Perit Dial Int       Date:  2016 11-12       Impact factor: 1.756

6.  Rural and micropolitan residence and mortality in patients on dialysis.

Authors:  Saugar Maripuri; Patrick Arbogast; T Alp Ikizler; Kerri L Cavanaugh
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

7.  Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.

Authors:  Marc Turenne; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Elizabeth Cope
Journal:  Health Serv Res       Date:  2017-05-30       Impact factor: 3.402

8.  Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.

Authors:  Virginia Wang; Cynthia J Coffman; Linda L Sanders; Shoou-Yih D Lee; Richard A Hirth; Matthew L Maciejewski
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-19       Impact factor: 8.237

9.  Impacts of Geographic Distance on Peritoneal Dialysis Utilization: Refining Models of Treatment Selection.

Authors:  Virginia Wang; Matthew L Maciejewski; Cynthia J Coffman; Linda L Sanders; Shoou-Yih Daniel Lee; Richard Hirth; Joseph Messana
Journal:  Health Serv Res       Date:  2016-04-07       Impact factor: 3.402

10.  Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.

Authors:  Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-21       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.